Crispr Therapeutics shares owned by Baker Bros. Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Baker Bros. Advisors
from 13F filings
Historical chart of Baker Bros. Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Baker Bros. Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $22M | 654k | 34.03 |
| 2024-12-31 | $52M | 1.3M | 39.36 |
| 2024-09-30 | $40M | 843k | 46.98 |
| 2024-06-30 | $5.4M | 100k | 54.01 |